United Kingdom· GB-APID-34736711000001102
Meriofert 75unit powder and solvent for solution for injection vials
A medicinal product containing menotrophin, registered in United Kingdom by IBSA Pharma Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Menotrophin
- Manufacturer
- IBSA Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin7612291498812
- gtin08033638952146
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Menotrophin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f3ebf215-606a-406d-bf7f-1f752d50c6f1 GET /v1/drugs/f3ebf215-606a-406d-bf7f-1f752d50c6f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34736711000001102",
"desc": "Meriofert 75unit powder and solvent for solution for injection vials (IBSA Pharma Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "4860511000001102",
"source": "dmd",
"vtm_id": "42777211000001100",
"strength": "75 unit",
"substance": "Menotrophin",
"ingredient": "Menotrophin",
"supplier_code": "15362811000001107"
}See everything about menotrophin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.